Cargando…
Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease
BACKGROUND: The typical approach to identify blood-derived gene expression signatures as a biomarker for Alzheimer’s disease (AD) have relied on training classification models using AD and healthy controls only. This may inadvertently result in the identification of markers for general illness rathe...
Autores principales: | Patel, Hamel, Iniesta, Raquel, Stahl, Daniel, Dobson, Richard J.B., Newhouse, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175937/ https://www.ncbi.nlm.nih.gov/pubmed/32065794 http://dx.doi.org/10.3233/JAD-191163 |
Ejemplares similares
-
A Meta-Analysis of Alzheimer’s Disease Brain Transcriptomic Data
por: Patel, Hamel, et al.
Publicado: (2019) -
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
por: Voyle, Nicola, et al.
Publicado: (2016) -
A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer’s Disease Diagnosis
por: Voyle, Nicola, et al.
Publicado: (2015) -
Differential gene expression analysis in blood of first episode psychosis patients
por: Leirer, Daniel J., et al.
Publicado: (2019) -
Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018)